Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sarah Forrester

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 9

Top Venues

Wellcome open research

PLoS neglected tropical diseases

Microorganisms

University of York

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of York Nov 1o 2018

United Kingdom

PDRA: Population genomics in Leishmania :: Department of Biology

Publications

Farah Shahi, Sarah Forrester, Kelly R Redeker, James P J Chong, Gavin Barlow
Case Report: The effect of intravenous and oral antibiotics on the gut microbiome and breath volatile organic compounds over one year. Wellcome open research 7 (2022)
Farah Shahi, Sarah Forrester, Kelly R Redeker, James P J Chong, Gavin Barlow
Case Report: The effect of intravenous and oral antibiotics on the gut microbiome and breath volatile organic compounds over one year. Wellcome open research 7 (2022)
Farah Shahi, Sarah Forrester, Kelly R Redeker, James P J Chong, Gavin Barlow
Case Report: The effect of intravenous and oral antibiotics on the gut microbiome and breath volatile organic compounds over one year. Wellcome open research 7 (2022)
Farah Shahi, Sarah Forrester, Kelly R Redeker, James P J Chong, Gavin Barlow
Case Report: The effect of intravenous and oral antibiotics on the gut microbiome and breath volatile organic compounds over one year. Wellcome open research 7 (2022)
Sarah Hendrickx, João Luís Reis-Cunha, Sarah Forrester, Daniel C Jeffares, Guy Caljon
Experimental Selection of Paromomycin Resistance in Leishmania donovani Amastigotes Induces Variable Genomic Polymorphisms. Microorganisms 9 (8) (2021)
Sarah Forrester, Karin Siefert, Helen Ashwin, Najmeeyah Brown, Andrea Zelmer, Sally James, Dimitris Lagos, Jon Timmis, Mitali Chatterjee, Jeremy Charles Mottram, Simon L Croft, Paul M Kaye
Tissue-specific transcriptomic changes associated with AmBisome® treatment of BALB/c mice with experimental visceral leishmaniasis. Wellcome open research 4 (2019)
Helen Ashwin, Karin Seifert, Sarah Forrester, Najmeeyah Brown, Sandy MacDonald, Sally James, Dimitris Lagos, Jon Timmis, Jeremy Charles Mottram, Simon L Croft, Paul M Kaye
Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis. Wellcome open research 3 (2019)
Helen Ashwin, Karin Seifert, Sarah Forrester, Najmeeyah Brown, Sandy MacDonald, Sally James, Dimitris Lagos, Jon Timmis, Jeremy Charles Mottram, Simon L Croft, Paul M Kaye
Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis. Wellcome open research (2019)
Mohamed Osman, Anoop Mistry, Ada Keding, Rhian Gabe, Elizabeth Cook, Sarah Forrester, Rebecca Wiggins, Stefania Di Marco, Stefano Colloca, Loredana Siani, Riccardo Cortese, Deborah F Smith, Toni Aebischer, Paul M Kaye, Charles J Lacey
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. PLoS neglected tropical diseases 11 (5) (2017)

Sarah Forrester.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sarah Forrester